SAEEDUDDIN AHMED
Pharmacy in Plainfield, IN
License number
Michigan 4301075258
Expiration Date
Jan 31, 2003
Category
Pharmacy
Type
CS - 3
Address
Address
Plainfield, IN 46168
Professional information
Method Of Treating Or Preventing Incontinence
US Patent:
2002010, Aug 8, 2002
Filed:
Jan 23, 2002
Appl. No.:
10/055663
Inventors:
Erik Wong - Portage MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert Marshall - Mattawan MI, US
Robert McArthur - Basel, CH
Duncan Taylor - Kalamazoo MI, US
Lars Birgerson - Martinsville NJ, US
Saeeduddin Ahmed - Plainfield IN, US
Robert Marshall - Mattawan MI, US
Robert McArthur - Basel, CH
Duncan Taylor - Kalamazoo MI, US
Lars Birgerson - Martinsville NJ, US
Assignee:
Pharmacia & Upjohn Company
International Classification:
A61K031/5377
US Classification:
514/238500
Abstract:
Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (K,)/norepinephrine (K) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
Method Of Treating Peripheral Neuropathy
US Patent:
7317011, Jan 8, 2008
Filed:
Jan 16, 2004
Appl. No.:
10/758864
Inventors:
Erik H. F. Wong - Portage MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert Clyde Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan P. Taylor - Kalamazoo MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert Clyde Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan P. Taylor - Kalamazoo MI, US
Assignee:
Pharmacia & Upjohn - Kalamazoo MI
International Classification:
A61K 31/535, A61K 31/537
US Classification:
5142392, 5142388
Abstract:
Disclosed herein are methods of treating an individual suffering from peripheral neuropathy. The methods generally include administration of a therapeutic amount of optically pure (S,S) reboxetine, or a pharmaceutically acceptable salt thereof. Embodiments of these methods can diminish adverse side effects.
Method Of Treating Migraine Headaches
US Patent:
2006014, Jun 29, 2006
Filed:
Feb 7, 2006
Appl. No.:
11/348948
Inventors:
Erik Wong - Portage MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan Taylor - Kalamazoo MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan Taylor - Kalamazoo MI, US
Assignee:
PHARMACIA & UPJOHN COMPANY - Kalamazoo MI
International Classification:
A61K 31/537
US Classification:
514238800
Abstract:
Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (K)/norepinephrine (K) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
Method Of Treating Chronic Fatigue Syndrome
US Patent:
7276503, Oct 2, 2007
Filed:
Feb 7, 2006
Appl. No.:
11/349373
Inventors:
Erik H. F. Wong - Portage MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert C. Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan P. Taylor - Kalamazoo MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert C. Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan P. Taylor - Kalamazoo MI, US
Assignee:
Pharmacia & Upjohn Company - Kalamazoo MI
International Classification:
A61K 35/535
US Classification:
5142392
Abstract:
Disclosed herein are methods of treating an individual suffering from, chronic fatigue syndrome. The methods generally include administration of a therapeutic amount of optically pure (S,S) reboxetine, or a pharmaceutically acceptable salt thereof, to the individual. Embodiments of these methods can diminish adverse side effects.
Method Of Treating A Psychotic Disorder
US Patent:
2006026, Nov 23, 2006
Filed:
Jul 28, 2006
Appl. No.:
11/460775
Inventors:
Erik Wong - Portage MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan Taylor - Kalamazoo MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan Taylor - Kalamazoo MI, US
Assignee:
PHARMACIA & UPJOHN COMPANY - Kalamazoo MI
International Classification:
A61K 31/537
US Classification:
514238800
Abstract:
Methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or a condition where inhibiting reuptake of norepinephrine is a benefit are disclosed. The compositions comprise a compound having a pharmacological selectivity of serotonin (K)/norepinephrine (K) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine. The methods generally include administration of a therapeutic amount of such compositions. Also disclosed are preparations of a medicament from the composition, and uses of the composition in a manufacture of the medicament to treat a human suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition.
Method Of Treating Chronic Fatigue Syndrome
US Patent:
7338953, Mar 4, 2008
Filed:
Feb 7, 2006
Appl. No.:
11/349331
Inventors:
Erik H. F. Wong - Portage MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert C. Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan P. Taylor - Kalamazoo MI, US
Lars Birgerson - Martinsville NJ, US
Saeeduddin Ahmed - Plainfield IN, US
Robert C. Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan P. Taylor - Kalamazoo MI, US
Lars Birgerson - Martinsville NJ, US
Assignee:
Pharmacia & Upjohn Company - Kalamazoo MI
International Classification:
A61K 35/535
US Classification:
5142392, 5142388
Abstract:
Disclosed herein are methods of treating an individual suffering from, chronic fatigue syndrome. The methods generally include administration of a therapeutic amount of racemic reboxetine, or a pharmaceutically acceptable salt thereof, to the individual.
Method Of Treating Peripheral Neuropathy
US Patent:
7241762, Jul 10, 2007
Filed:
Feb 7, 2006
Appl. No.:
11/349022
Inventors:
Erik H. F. Wong - Portage MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert C. Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan P. Taylor - Kalamazoo MI, US
Saeeduddin Ahmed - Plainfield IN, US
Robert C. Marshall - Mattawan MI, US
Robert McArthur - Kalamazoo MI, US
Duncan P. Taylor - Kalamazoo MI, US
Assignee:
Pharmacia & Upjohn Company - Kalamazoo MI
International Classification:
A61K 35/535
US Classification:
5142392, 5142388
Abstract:
Disclosed herein are methods of treating an individual suffering from peripheral neuropathy. The methods generally include administration of a therapeutic amount of racemic reboxetine, or a pharmaceutically acceptable salt thereof, to the individual.